Home › Funds › Vest Financial, LLC › ABT

Vest Financial, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Vest Financial, LLC reported holding 671,539 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$66.4M, representing 0.70% of its reported portfolio and ranking #38 among its reported holdings. Vest Financial, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)671.54K sh
Reported value held$66.37M
Portfolio Weight0.70%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vest Financial, LLC's ABT position evolved

Vest Financial, LLC first disclosed a stake in ABT in Q3 2023 at 289,688 shares (US$28.1M). The position peaked in Q4 2025 at 810,893 shares, worth US$101.6M. Across 13 filings, Vest Financial, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 671,539 shares valued at US$66.4M — a reduction of -134,098 shares quarter over quarter.. Notable position changes include a 39% increase in Q4 2023 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 289.69K $28.06M New
Q4 2023 401.90K $44.24M Add
Q1 2024 342.92K $38.98M Reduce
Q2 2024 416.47K $43.28M Add
Q3 2024 470.36K $53.63M Add
Q4 2024 500.31K $56.59M Add
Q1 2025 528.49K $70.10M Add
Q2 2025 592.30K $80.56M Add
Q3 2025 728.65K $97.60M Add
Q4 2025 810.89K $101.60M Add
Q1 2026 797.52K $81.88M Reduce
Q2 2026 805.64K $73.10M Add
Q3 2026 671.54K $66.37M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Vest Financial, LLC held ABT?

Vest Financial, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Vest Financial, LLC's current position in ABT?

As of Q3 2026, Vest Financial, LLC holds 671.54K shares of ABT (ABBOTT LABORATORIES), valued at $66.37M, representing 0.70% of its reported portfolio and ranking #38.

Has Vest Financial, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Vest Financial, LLC reduced its position in ABT. The position peaked in Q4 2025 at 810.89K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.